Ravneet Thind — University of Kentucky

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

Post Doctoral Fellow, Other Institution

2014

Residency, Other Institution

2008

Bachelor of Medicine, Bachelor of Surgery, Kasturba Medical College

2001

1 Active
9 Finished

A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy
Villano, J. & Thind, R.
Orbus Therapeutics Incorporated
9/1/16 → 1/5/24
Project: Research project
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined with Bevacizumab vs. Bevacizumab Monotherapy in Patients with Recurrent Glioblastoma
Villano, J. & Thind, R.
PPD Investigator Services LLC
5/13/16 → 5/12/18
Project: Research project
15-LUN-100-HR: A Phase III, Open-label, Randomized Study of Atezolizumab (MPDL3280A, ANTI-PD-L1 Antibody) in Combination With Carboplatin or Cisplatin + Pemetrexed In Patients Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous
Arnold, S., Anthony, L., Thind, R., Villano, J. & Hosein, P.
Genentech Inc
4/29/16 → 10/20/20
Project: Research project
15-NEURO-06-NLG (NLG-2102) A Phase 1/2 Study of the Combination of Indoximod + Temozolomide for Adult Patients with Temozolomide-Refractory Primary Malignant Brain Tumors
Villano, J., St Clair, W. & Thind, R.
NewLink Genetics
3/4/16 → 11/14/19
Project: Research project
15-28-HN-28-GT (GT-201): A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Effects of Intravenous GC4419 on the Incidence and Duration of Severe Oral Mucositis (OM) in Patients Receiving Post-Operative or Definitive Therapy
Kudrimoti, M., Arnold, S., St Clair, W. & Thind, R.
Galera Therapeutics Incorporated
2/24/16 → 2/23/18
Project: Research project